SCHEMBL20850797

SCHEMBL20850797

C[C@@](O)(c1ccccc1)[C@H]1CCCCCN1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 3/20 0.61
KDM4E B2RXH2 1/20 0.61
NPC1 O15118 1/20 0.61
CYP1A2 P05177 1/20 0.61
HPGD P15428 1/20 0.61
MAPK1 P28482 1/20 0.61
CYP2C19 P33261 1/20 0.61
RAB9A P51151 1/20 0.61
LMNA P02545 2/20 0.41
MEN1 O00255 1/20 0.41
HRH1 P35367 1/20 0.41
SCN1A P35498 1/20 0.41
KMT2A Q03164 1/20 0.41
SCN2A Q99250 1/20 0.41
SCN3A Q9NY46 1/20 0.41
SLC6A3 Q01959 5/20 0.40
SLC6A2 P23975 3/20 0.40
SLC6A4 P31645 2/20 0.40
POLB P06746 1/20 0.40
KEAP1 Q14145 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20833279 0.98 CYP2D6 (0.63) CYP2D6KDM4ENPC1CYP1A2HPGD
SCHEMBL20833147 0.98 CYP2D6 (0.63) CYP2D6KDM4ENPC1CYP1A2HPGD
SCHEMBL20833053 0.98 CYP2D6 (0.63) CYP2D6KDM4ENPC1CYP1A2HPGD
SCHEMBL14227426 0.93 CYP2D6 (0.70) CYP2D6KDM4ENPC1CYP1A2HPGD
SCHEMBL16931709 0.93 CYP2D6 (0.70) CYP2D6KDM4ENPC1CYP1A2HPGD
SCHEMBL14227427 0.93 CYP2D6 (0.70) CYP2D6KDM4ENPC1CYP1A2HPGD
SCHEMBL19841237 0.93 CYP2D6 (0.70) CYP2D6KDM4ENPC1CYP1A2HPGD
SCHEMBL20833321 0.93 CYP2D6 (0.70) CYP2D6KDM4ENPC1CYP1A2HPGD
SCHEMBL3088977 0.93 CYP2D6 (0.70) CYP2D6KDM4ENPC1CYP1A2HPGD
SCHEMBL16640675 0.93 CYP2D6 (0.70) CYP2D6KDM4ENPC1CYP1A2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3066076-B1 PROCESS FOR THE PREPARATION OF METHYLPHENIDATE AND PHARMACEUTICAL SALTS THEREOF NORAMCO INC (US) 2019-03-27 EP disclosed